Transitioning from static to suspension culture system for large‐scale production of xeno‐free extracellular vesicles derived from mesenchymal stromal cells
Biotechnology Progress · 2024
DOI: 10.1002/btpr.3419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Natália Cristine Dias Dos Santos und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles, Cell Culture Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development (CNPq), São Paulo Research Foundation (FAPESP), FAPESP-CTC.
Abstract (Originalsprache)
Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) have shown increasing therapeutic potential in the last years. However, large production of EV is required for therapeutic purposes. Thereby, scaling up MSC cultivation in bioreactors is essential to allow culture parameters monitoring. In this study, we reported the establishment of a scalable bioprocess to produce MSC‐EV in suspension cultures using spinner flasks and human collagen‐coated microcarriers (3D culture system). We compared the EV production in this 3D culture system with the standard static culture using T‐flasks (2D culture system). The EV produced in both systems were characterized and quantify by western blotting and nanoparticle tracking analysis. The presence of the typical protein markers CD9, CD63, and CD81 was confirmed by western blotting analyses for EV produced in both culture systems. The cell fold‐increase was 5.7‐fold for the 3D culture system and 4.6‐fold for the 2D culture system, signifying a fold‐change of 1.2 (calculated as the ratio of fold‐increase 3D to fold‐increase 2D). Furthermore, it should be noted that the total cell production in the spinner flask cultures was 4.8 times higher than that in T‐flask cultures. The total cell production in the spinner flask cultures was 5.2‐fold higher than that in T‐flask cultures. While the EV specific production (particles/cell) in T‐flask cultures (4.40 ± 1.21 × 10 8 particles/mL, p < 0.05) was higher compared to spinner flask cultures (2.10 ± 0.04 × 10 8 particles/mL, p < 0.05), the spinner flask culture system offers scalability, making it capable of producing enough MSC‐EV at a large scale for clinical applications. Therefore, we concluded that 3D culture system evaluated here serves as an efficient transitional platform that enables the scaling up of MSC‐EV production for therapeutic purposes by utilizing stirred tank bioreactors and maintaining xeno‐free conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
- Department of Pharmaceutical Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
- Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
- Department of Clinical Analysis, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
ORCID-Profile: Paula Bruzadelle-Vieira, Amanda Mizukami-Martins, Kelen Cristina Ribeiro Malmegrim
Förderung
- National Council for Scientific and Technological Development (CNPq)
- São Paulo Research Foundation (FAPESP)
- FAPESP-CTC
- INCT-Nanofarma
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Dos Santos, N. C. D., Bruzadelle-Vieira, P., de Cássia Noronha, N., Mizukami-Martins, A., Orellana, M. D., Bentley, M. V. L. B., Covas, D. T., Swiech, K., & Malmegrim, K. C. R. (2024). Transitioning from static to suspension culture system for large‐scale production of xeno‐free extracellular vesicles derived from mesenchymal stromal cells. Biotechnology Progress. https://doi.org/10.1002/btpr.3419
Vancouver
Dos Santos NCD, Bruzadelle-Vieira P, de Cássia Noronha N, Mizukami-Martins A, Orellana MD, Bentley MVLB, et al. Transitioning from static to suspension culture system for large‐scale production of xeno‐free extracellular vesicles derived from mesenchymal stromal cells. Biotechnology Progress. 2024. doi:10.1002/btpr.3419
BibTeX
@article{DosSantos2024,
author = {Dos Santos, Natália Cristine Dias and Bruzadelle-Vieira, Paula and de Cássia Noronha, Nádia and Mizukami-Martins, Amanda and Orellana, Maristela Delgado and Bentley, Maria Vitória L B and Covas, Dimas Tadeu and Swiech, Kamilla and Malmegrim, Kelen Cristina Ribeiro},
title = {Transitioning from static to suspension culture system for large‐scale production of xeno‐free extracellular vesicles derived from mesenchymal stromal cells},
journal = {Biotechnology Progress},
year = {2024},
doi = {10.1002/btpr.3419}
}
EUVIMED